Online citations, reference lists, and bibliographies.
← Back to Search

Optimizing Interstitial Delivery Of BCNU From Controlled Release Polymers For The Treatment Of Brain Tumors

E. P. Sipos, B. Tyler, S. Piantadosi, P. Burger, H. Brem
Published 1997 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Two approaches for improving the interstitial administration of carmustine (BCNU) using 3.8% loaded poly(carboxyphenoxypropane-sebacic acid), an implantable biodegradable anhydride which significantly prolongs survival in patients with recurrent malignant gliomas, were evaluated. First, increasing the ratio of carboxyphenoxypropane (CPP) to sebacic acid (SA) in the polymer increases its hydrolytic stability, thus prolonging its half-life in vivo, and extending the period of drug release. A second approach is to increase the dose of drug loaded into the polymer. This study evaluated the relative merits of these two approaches by comparing release kinetics, safety, and efficacy of escalating BCNU doses in polymers with 20:80 and 50:50 ratios of CPP to SA.At the highest dose tested, the 50:50 polymer released BCNU 2.5 times as long in vitro as the 20:80 polymer. Both formulations were nontoxic in rat brains for all BCNU doses tested except 32%. The 20:80 and 50:50 polymers were equally effective in the rat intracranial 9L-glioma model. A dose-response relationship for BCNU was observed (hazard ratio 0.8354 for each mg/kg increase, P<0.001). The two highest loading doses of BCNU improved survival 40-fold (P<0.001). The 20% BCNU-loaded 20:80 polymer achieved the best balance of toxicity and antitumor efficacy, yielding a 75% long-term survival rate. Further evaluation of this polymer in monkeys suggests that it might be used with acceptable toxicity. This study establishes that a dose-escalation strategy for improving BCNU controlled-release polymers is more effective than adjusting the ratio of CPP to SA to prolong drug release.
This paper references
Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
M. Yang (1989)
Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
R. Tamargo (1993)
10.3171/JNS.1985.63.6.0876
The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
F. Hochberg (1985)
10.1002/JBM.820280314
In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
M. Wu (1994)
10.3171/JNS.1988.68.1.0001
Chemotherapy for malignant gliomas.
P. Kornblith (1988)
10.3171/JNS.1992.76.4.0640
The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.
S. Grossman (1992)
10.3171/JNS.1991.74.3.0441
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
H. Brem (1991)
Regression models and life tables (with discussion
D. Cox (1972)
10.1002/JBM.820230209
Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
R. Tamargo (1989)
10.3171/JNS.1994.80.2.0283
Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
H. Brem (1994)
Nonneoplastic lesions in the cardiovascular system
D Lewis (1992)
10.1227/00006123-199512000-00013
Intratumoral chemotherapy.
K. Walter (1995)
10.5860/choice.51-0615
The Merck index
S. Budavari (1998)
10.1002/POLA.1987.080251217
Polyanhydrides. I: Preparation of high molecular weight polyanhydrides
A. Domb (1987)
10.1089/SCT.1989.5.55
Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
H. Brem (1989)
10.1016/S0031-3025(16)36070-6
Pathology of the Fischer Rat — Reference and Atlas
S. Bain (1991)
10.1016/S0140-6736(95)90755-6
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
H. Brem (1995)



This paper is referenced by
UNIVERSITÁ DEGLI STUDI DI MILANO FACOLTÁ DI MEDICINA E CHIRURGIA
Dottorato Di Ricerca (2010)
10.1016/S0360-3016(00)00428-4
Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
M. Khil (2000)
10.1080/02688690220148860
Phase I clinical trial on adjuvant active immunotherapy of human gliomas with GD2-conjugate
R. Becker (2002)
10.1016/J.EJPB.2004.06.006
Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
J. Lee (2005)
10.1016/j.ejps.2009.03.010
Delivery of bioactive macromolecules from microporous polymer matrices: Release and activity profiles of lysozyme, collagenase and catalase.
Y. Wang (2009)
IJPT Solid Lipid Nanoparticles: An Over Review
Shashidher Burra (2011)
(54) COMPOSITIONS AND METHODS FOR TARGETED IN VITRO AND IN VIVO DRUG DELIVERY TO MAMMALIAN CELLS VIA BACTERIALLY DERIVED INTACT MINICELLS
(2016)
10.1177/153303460900800108
Growth Inhibition against Intracranial C6 Glioma Cells by Stereotactic Delivery of BCNU by Controlled Release from poly(D,L-lactic acid) Nanoparticles
C. Kang (2009)
10.1016/B978-0-12-803796-6.00017-4
Chapter 17 – Brain Tumors
Sibel Bozdağ-Pehlivan (2017)
3 Cytotoxicity of Tamoxifen-Loaded Solid Lipid Nanoparticles
A. Salehzadeh (2012)
10.1007/s11060-005-3030-x
Systemic Temozolomide Combined with Loco-regional Mitoxantrone in Treating Recurrent Glioblastoma
A. Boiardi (2005)
10.1002/jps.22027
Micro-CT analysis of matrix-type drug delivery devices and correlation with protein release behaviour.
Y. Wang (2010)
10.1016/J.JCONREL.2006.05.031
BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells.
X. Xu (2006)
10.13130/FINATI-ELENA_PHD2013-02-19
Melatonin: a pleiotropic molecule of natural origin. Evaluation of the different therapeutic activities in animal models and / or human patients and a study of the metabolic-biochemical pathways related to them.
E. Finati (2013)
10.3109/02652049809008261
Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
M. S. Reza (1998)
10.1177/107327489800500204
Implantable Slow-Release Chemotherapeutic Polymers for the Treatment of Malignant Brain Tumors.
Sampath (1998)
10.1007/978-3-642-56411-6_18
Radiation Therapy Principles for High-Grade Gliomas
C. Miyamoto (2003)
10.1080/026520499288753
Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization.
W. Chen (1999)
10.1007/978-3-319-11274-9_37
Oncologic Treatment of Pediatric Brainstem Tumors
C. Canpolat (2015)
10.1016/j.jconrel.2016.03.031
Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
A. Mangraviti (2016)
10.1227/01.NEU.0000365263.14725.39
Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model
V. Recinos (2010)
10.1158/1078-0432.CCR-18-3850
Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste
S. Smith (2019)
10.1007/978-1-4614-9434-8
Focal Controlled Drug Delivery
A. Domb (2014)
10.3109/13550289809114520
Principles of treatment of malignant gliomas in adults: an overview.
S. Azizi (1998)
10.1016/S0378-5173(02)00543-4
BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
H. Seong (2003)
10.1385/1-59259-899-4:297
Local Delivery Methods Into the CNS
T. W. Vogel (2005)
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
L. Rhines (2000)
10.1097/00001622-200005000-00001
Local drug delivery
R. I. Haroun (2000)
10.1016/j.jconrel.2017.07.009
Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.
Panagiotis Mastorakos (2017)
10.6004/JNCCN.2005.0042
Local treatment of malignant brain tumors using implantable chemotherapeutic polymers.
G. Gallia (2005)
10.1023/B:DRUG.0000006172.65135.3e
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
C. Guérin (2004)
10.1007/978-1-4614-9434-8_7
Treatment of Brain Tumors
B. Tyler (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar